Should I buy IRT Living (IRT) stock or is it too late?

IRT Living · Real Estate · price $15

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (32 calls tested). It aims for $18 (+21 %), call made on September 16, 2026, maturing on September 16, 2027 (28 d ago).

The 2 reliable analysts $18.50+25 %

The 3 other firms $20+35 %

How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $18.50 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on IRT Living

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Keybanc	50 %	+8.6 %	10	$21 +41%
JMP Securities	46 %	+4.0 %	13	$25 +68%
RBC Capital	40 %	+3.8 %	5	$19 +28%
Deutsche Bank	40 %	+3.2 %	5	$22 +48%
Barclays	20 %	-7.7 %	5	$20 +35%

In short — Should you invest in IRT Living? Is it too late, still worth it? Analysts are overwhelmingly positive (100% buy, median target $19, i.e. +28%), and the most reliable on IRT targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

100% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
Median price target $19, i.e. +28% from the current price ($15).
The most reliable firm on IRT, BMO Capital (50% hit rate, 2 scored calls), targets $22 (call made on January 9, 2026, maturing on January 9, 2027) (+48%) in its most recent call.
Pays a dividend (4.0% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

A 12-month target is not a guaranteed path: the price can fall in the meantime.
A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.

The analyst consensus on IRT

Median target $19 (+28%) · 5 ratings · Buy consensus

Strong Buy00%

Buy5100%

Hold00%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in IRT Living now?

We won't decide for you. The facts: 100% of analysts rate it a buy, median target $19 (+28%), and BMO Capital (most reliable on IRT, 50%) targets $22. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in IRT Living?

Not according to analysts: the median target ($19) is still +28% above the current price ($15) (most reliable on IRT: BMO Capital, 50%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is IRT Living still worth investing in?

It depends on the gap between the price ($15) and its estimated value: analysts target $19 on median (+28%), with 100% buys (most reliable on IRT: BMO Capital, 50%). Cross-check with their real reliability on IRT and the cautions above. Information, not advice.

What's the main risk in buying IRT?

A 12-month target is not a guaranteed path: the price can fall in the meantime.

→ Go deeper: the full IRT Living profile (consensus, analyst reliability, price target, performance).